|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
15
|
|
pubmed:dateCreated |
2007-5-21
|
|
pubmed:abstractText |
To evaluate treatment outcome of patients with early-stage favorable Hodgkin's lymphoma (HL) who experience disease relapse after primary treatment with two cycles of chemotherapy followed by radiotherapy (RT).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2000-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17420510-Adolescent,
pubmed-meshheading:17420510-Adult,
pubmed-meshheading:17420510-Aged,
pubmed-meshheading:17420510-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17420510-Combined Modality Therapy,
pubmed-meshheading:17420510-Disease Progression,
pubmed-meshheading:17420510-Female,
pubmed-meshheading:17420510-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:17420510-Hodgkin Disease,
pubmed-meshheading:17420510-Humans,
pubmed-meshheading:17420510-Male,
pubmed-meshheading:17420510-Middle Aged,
pubmed-meshheading:17420510-Neoplasm Recurrence, Local,
pubmed-meshheading:17420510-Remission Induction,
pubmed-meshheading:17420510-Retrospective Studies,
pubmed-meshheading:17420510-Risk Factors,
pubmed-meshheading:17420510-Salvage Therapy,
pubmed-meshheading:17420510-Survival Rate,
pubmed-meshheading:17420510-Time Factors
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
|
|
pubmed:affiliation |
First Department of Internal Medicine, University Hospital Cologne, Cologne, Germany. Michal.Sieniawski@ncl.ac.uk
|
|
pubmed:publicationType |
Journal Article
|
